Could high FAI in women indicate PCOS?

High Free Androgen Index (FAI) in women can indicate PCOS, as elevated androgens are a key diagnostic criterion. FAI measures biologically active testosterone and is often elevated in women with PCOS.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

If you've been experiencing symptoms like irregular periods, acne, unwanted hair growth, or difficulty losing weight, your healthcare provider may have mentioned testing your Free Androgen Index (FAI). This important biomarker can provide crucial insights into your hormonal health and may help identify conditions like Polycystic Ovary Syndrome (PCOS). Understanding the connection between elevated FAI levels and PCOS can be the first step toward getting the answers and treatment you need.

What is the Free Androgen Index (FAI)?

The Free Androgen Index (FAI) is a calculated measurement that estimates the amount of biologically active testosterone in your bloodstream. Unlike total testosterone, which includes both bound and unbound hormone, FAI specifically measures the testosterone that's available to interact with your body's tissues and cells.

FAI is calculated using the formula: (Total Testosterone ÷ Sex Hormone-Binding Globulin) × 100. Sex Hormone-Binding Globulin (SHBG) is a protein that binds to testosterone, making it inactive. When SHBG levels are low, more testosterone remains free and active, resulting in a higher FAI. This calculation provides a more accurate picture of androgen activity than measuring total testosterone alone.

Conditions Associated with High FAI in Women

FAI levels should always be interpreted alongside clinical symptoms and additional diagnostic tests for accurate diagnosis.
ConditionTypical FAI RangeKey SymptomsAdditional Tests Needed
PCOSPCOS5-15+Irregular periods, hirsutism, acne, weight gainLH/FSH ratio, pelvic ultrasound, glucose tolerance test
Congenital Adrenal HyperplasiaCongenital Adrenal Hyperplasia10-25+Early puberty, rapid growth, severe hirsutism17-hydroxyprogesterone, cortisol, ACTH stimulation test
Androgen-secreting TumorAndrogen-secreting Tumor15-50+Rapid onset virilization, severe symptomsImaging studies (CT/MRI), DHEA-S, androstenedione
Cushing's SyndromeCushing's Syndrome8-20Central obesity, purple striae, muscle weakness24-hour urine cortisol, dexamethasone suppression test

FAI levels should always be interpreted alongside clinical symptoms and additional diagnostic tests for accurate diagnosis.

Normal FAI Ranges for Women

For women, normal FAI levels typically range from 1 to 5. Values above 5 are generally considered elevated and may indicate hyperandrogenism, a condition characterized by excess androgen activity. However, it's important to note that reference ranges can vary slightly between laboratories, and your healthcare provider will interpret your results in the context of your symptoms and overall health picture.

The Connection Between High FAI and PCOS

PCOS is one of the most common hormonal disorders affecting women of reproductive age, impacting up to 10% of women worldwide. One of the key diagnostic criteria for PCOS is hyperandrogenism, which can be identified through elevated androgen levels in blood tests or clinical signs of excess androgens.

High FAI levels are strongly associated with PCOS because women with this condition often have elevated testosterone production from their ovaries and adrenal glands, combined with decreased SHBG levels. This combination results in significantly higher amounts of biologically active testosterone circulating in the bloodstream.

Why FAI is Elevated in PCOS

Several mechanisms contribute to elevated FAI in women with PCOS:

  • Increased testosterone production by the ovaries due to elevated luteinizing hormone (LH) levels
  • Enhanced androgen production by the adrenal glands
  • Decreased SHBG production by the liver, often related to insulin resistance
  • Insulin resistance leading to increased androgen synthesis

Understanding these hormonal imbalances is crucial for proper diagnosis and treatment. Regular monitoring of FAI and related hormones can help track treatment progress and optimize management strategies.

Symptoms Associated with High FAI

When FAI levels are elevated, women may experience a range of symptoms related to excess androgen activity. These symptoms can significantly impact quality of life and may develop gradually over time.

Physical Symptoms

  • Hirsutism (excessive hair growth on face, chest, back, or abdomen)
  • Male-pattern baldness or hair thinning
  • Acne, particularly along the jawline and back
  • Deepening of the voice
  • Increased muscle mass
  • Clitoral enlargement (in severe cases)

Reproductive and Metabolic Symptoms

  • Irregular or absent menstrual periods
  • Difficulty conceiving or infertility
  • Weight gain, particularly around the midsection
  • Insulin resistance and increased risk of type 2 diabetes
  • Mood changes, including depression and anxiety

It's important to note that not all women with high FAI will experience every symptom, and symptom severity can vary significantly between individuals. Some women may have elevated FAI levels with minimal visible symptoms, while others may experience multiple severe manifestations.

Other Conditions That Can Cause High FAI

While PCOS is the most common cause of elevated FAI in women, several other conditions can also lead to increased androgen activity:

Endocrine Disorders

  • Congenital adrenal hyperplasia (CAH)
  • Cushing's syndrome
  • Thyroid disorders
  • Androgen-secreting tumors of the ovaries or adrenal glands

Lifestyle and Medication Factors

  • Anabolic steroid use
  • Certain medications (danazol, testosterone therapy)
  • Severe insulin resistance or metabolic syndrome
  • Obesity, which can lower SHBG levels

Understanding these various causes is essential for proper diagnosis and treatment planning. Your healthcare provider will consider your complete medical history, symptoms, and additional test results to determine the underlying cause of elevated FAI levels.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Criteria for PCOS

PCOS diagnosis is based on the Rotterdam criteria, which require the presence of at least two of the following three features:

  1. Oligo-ovulation or anovulation (irregular or absent ovulation)
  2. Clinical and/or biochemical signs of hyperandrogenism
  3. Polycystic ovaries on ultrasound

High FAI levels fall under the second criterion as biochemical evidence of hyperandrogenism. However, it's important to note that PCOS is a diagnosis of exclusion, meaning other conditions that can cause similar symptoms must be ruled out first.

Additional Tests for PCOS Diagnosis

Beyond FAI, healthcare providers typically order several other tests to confirm PCOS diagnosis:

  • Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) ratio
  • Prolactin levels to rule out prolactinoma
  • Thyroid function tests (TSH, Free T4)
  • 17-hydroxyprogesterone to exclude congenital adrenal hyperplasia
  • Fasting glucose and insulin levels
  • Lipid profile
  • Pelvic ultrasound to assess ovarian morphology

Testing Your FAI and Hormone Levels

If you're experiencing symptoms that could indicate hormonal imbalances, getting your FAI and related hormones tested is an important step toward understanding your health. The timing of hormone testing can be crucial, particularly for women with regular menstrual cycles.

When to Test

For women with regular cycles, hormone testing is typically recommended during the follicular phase (days 3-5 of the menstrual cycle) when hormone levels are most stable. However, women with irregular cycles or suspected PCOS can be tested at any time, as their hormone patterns are already disrupted.

Fasting is generally not required for FAI testing, but if other metabolic markers like glucose and insulin are being measured simultaneously, your healthcare provider may recommend fasting for 8-12 hours before the blood draw.

What to Expect from Testing

FAI testing involves a simple blood draw that measures both total testosterone and SHBG levels. The laboratory then calculates your FAI using these values. Results are typically available within a few days, and your healthcare provider will interpret them in the context of your symptoms and medical history.

Managing High FAI and PCOS

If testing confirms elevated FAI levels and a PCOS diagnosis, several treatment approaches can help manage symptoms and reduce long-term health risks. Treatment plans are typically individualized based on your specific symptoms, reproductive goals, and overall health status.

Lifestyle Interventions

Lifestyle modifications form the foundation of PCOS management and can significantly impact FAI levels:

  • Weight management through a balanced, low-glycemic diet
  • Regular physical exercise, including both cardio and strength training
  • Stress reduction techniques like meditation or yoga
  • Adequate sleep (7-9 hours per night)
  • Limiting processed foods and added sugars

Medical Treatments

Depending on your symptoms and goals, your healthcare provider may recommend:

  • Hormonal contraceptives to regulate cycles and reduce androgen levels
  • Anti-androgen medications like spironolactone for hirsutism and acne
  • Metformin to improve insulin sensitivity
  • Fertility treatments if pregnancy is desired
  • Topical treatments for acne and hair removal options for hirsutism

Monitoring Progress

Regular follow-up testing is essential to monitor treatment effectiveness and adjust management strategies as needed. FAI levels, along with other hormone markers, should be reassessed every 3-6 months during active treatment to track progress and optimize care.

Long-term Health Implications

Women with persistently high FAI levels and PCOS face increased risks for several long-term health complications. Understanding these risks emphasizes the importance of early diagnosis and consistent management.

Metabolic Complications

  • Type 2 diabetes (risk increased by 5-10 times)
  • Metabolic syndrome
  • Cardiovascular disease
  • Non-alcoholic fatty liver disease
  • Sleep apnea

Reproductive Health Risks

  • Infertility due to irregular ovulation
  • Increased risk of pregnancy complications
  • Higher rates of miscarriage
  • Endometrial cancer risk due to unopposed estrogen exposure

The good news is that many of these risks can be significantly reduced through proper management and regular monitoring. Early intervention and consistent care can help women with high FAI and PCOS maintain excellent long-term health outcomes.

Taking Control of Your Hormonal Health

Understanding the relationship between high FAI levels and PCOS empowers you to take proactive steps toward better hormonal health. If you're experiencing symptoms like irregular periods, unwanted hair growth, persistent acne, or difficulty managing your weight, don't dismiss these signs as normal variations.

Early detection and management of hormonal imbalances can prevent many long-term complications and significantly improve your quality of life. Work with healthcare providers who understand the complexity of hormonal health and are committed to helping you achieve optimal wellness.

Remember that PCOS and high FAI levels are manageable conditions. With the right combination of lifestyle modifications, medical treatment when appropriate, and regular monitoring, you can successfully manage your symptoms and reduce your risk of long-term complications. Your hormonal health is an investment in your overall well-being and future quality of life.

References

  1. Teede, H. J., Misso, M. L., Costello, M. F., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602-1618.[PubMed][DOI]
  2. Azziz, R., Carmina, E., Chen, Z., et al. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2, 16057.[PubMed][DOI]
  3. Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology & Metabolism, 84(10), 3666-3672.[PubMed][DOI]
  4. Legro, R. S., Arslanian, S. A., Ehrmann, D. A., et al. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 98(12), 4565-4592.[PubMed][DOI]
  5. Hoeger, K. M., Dokras, A., & Piltonen, T. (2021). Update on PCOS: consequences, challenges, and guiding treatment. Journal of Clinical Endocrinology & Metabolism, 106(3), e1071-e1083.[PubMed][DOI]
  6. Barber, T. M., Hanson, P., Weickert, M. O., & Franks, S. (2019). Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clinical Medicine Insights: Reproductive Health, 13, 1179558119874042.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my FAI at home?

You can test your Free Androgen Index (FAI) at home with SiPhox Health's Hormone Focus Program, which includes FAI testing along with other key hormone biomarkers like testosterone, SHBG, LH, FSH, and more. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is considered a high FAI level for women?

For women, FAI levels above 5 are generally considered elevated and may indicate hyperandrogenism. Normal FAI ranges typically fall between 1-5, though reference ranges can vary slightly between laboratories.

Can high FAI levels be lowered naturally?

Yes, lifestyle modifications can help lower FAI levels naturally. Weight management, regular exercise, a low-glycemic diet, stress reduction, and adequate sleep can all help improve hormone balance and reduce FAI levels over time.

How often should I test my FAI if I have PCOS?

If you have PCOS or elevated FAI levels, most experts recommend testing every 3-6 months during active treatment to monitor progress and adjust management strategies as needed.

Can birth control affect FAI levels?

Yes, hormonal contraceptives can significantly lower FAI levels by increasing SHBG production and suppressing ovarian androgen production. This is why birth control is often prescribed as a treatment for PCOS-related symptoms.

Is high FAI always a sign of PCOS?

No, while high FAI is strongly associated with PCOS, other conditions can also cause elevated levels, including congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors, and certain medications. Proper medical evaluation is needed for accurate diagnosis.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details